Drug intelligence / Profile preview

Medi-Flamme

Development stage: Preclinical
Lead developer: Bionyeri
Modality: Small Molecules
Administration: Topical

Overview

Medi-Flamme is a natural topical cream developed by Bionyeri for the relief of inflammation and muscle pain. Described as a plant-based formulation, it leverages Bionyeri's focus on bioactive plant extracts and AI-driven optimization for enhanced drug delivery. The product is intended to provide analgesic and anti-inflammatory effects through topical application. While specific molecular targets are not publicly disclosed, the product is part of a pipeline that utilizes PC2 accredited facilities for formulation and development. It has been trademarked in Australia and Indonesia, reflecting its advancement toward commercial registration and market entry.

Brand names: Medi-Flamme
Other names: IM-01-Bionyeri-topical cream-topicalIM01-Bionyeri-topical cream-topicalIM 01-Bionyeri-topical cream-topical

Beyond the preview

Go deeper on Medi-Flamme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medi-Flamme.

Explore the full profile